Quarterly report pursuant to Section 13 or 15(d)

12. Segments

v3.10.0.1
12. Segments
9 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segments

12. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

    Nine Months Ended December 31,  
    2018     2017  
Revenues:            
Aethlon   $ 149,625     $ 74,813  
ESI            
Total Revenues   $ 149,625     $ 74,813  
                 
Operating Losses:                
Aethlon   $ (4,304,082 )   $ (3,495,189 )
ESI     (104,017 )     (64,860 )
Total Operating Loss   $ (4,408,099 )   $ (3,560,049 )
                 
Net Losses:                
Aethlon   $ (4,469,399 )   $ (4,308,807 )
ESI     (104,017 )     (64,860 )
Net Loss Before Non-Controlling Interests   $ (4,573,416 )   $ (4,373,667 )
                 
Cash:                
Aethlon   $ 4,824,225     $ 5,610,061  
ESI     676       738  
Total Cash   $ 4,824,901     $ 5,610,799  
                 
Total Assets:                
Aethlon   $ 4,950,079     $ 5,745,031  
ESI     676       5,723  
Total Assets   $ 4,950,755     $ 5,750,754  
                 
Capital Expenditures:                
Aethlon   $     $ 23,705  
ESI            
Capital Expenditures   $     $ 23,705  
                 
Depreciation and Amortization:                
Aethlon   $ 24,756     $ 27,402  
ESI            
Total Depreciation and Amortization   $ 24,756     $ 27,402  
                 
Interest Expense:                
Aethlon   $ (165,317 )   $ (306,495 )
ESI            
Total Interest Expense   $ (165,317 )   $ (306,495 )